TriSalus Life Sciences, Inc. (TLSI) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 6, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 6, 2026 filed July 1, 2026 | Patience David Chief Financial Officer | $65,339 | 14,650 | −5% | No | |
|
|
||||||
| July 1, 2026 filed June 30, 2026 | Szela Mary T CEO and President | $15,441 | 3,990 | +0% | No | |
|
|
||||||
| July 1, 2026 filed June 30, 2026 | Marshak Richard Chief Commercial Officer | $2,171 | 561 | +0% | No | |
|
|
||||||
| June 29, 2026 | Marshall Richard Henry Chief Medical Officer | $0 | 180,000 | +31% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free